New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Plaque psoriasis can also affect the scalp ... Eczema tends to run in families, especially in those prone to allergies and ...

A person with plaque psoriasis breaks out in a rash that most ... underlying genetic and environmental factors. Food allergies, asthma, and allergic rhinitis are often linked with eczema.

In 2013, itolizumab received approval in India as a safe and effective treatment for plaque psoriasis ... and uncontrolled asthma (EQUIP). Although T eff cells are known to play a central role ...

(RTTNews) - Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO ...